## Abstract The pleomorphic pathology of postmortem __LRRK2__‐positive patients and the frequent association with late‐onset Parkinson's disease (LOPD) symptoms suggest that __LRRK2__ mutations may play a role in Parkinson's Plus disorders and LOPD. Published studies primarily focus on the common G
Recurrent LRRK2 (Park8) mutations in early-onset Parkinson's disease
✍ Scribed by Katja Hedrich; Susen Winkler; Johann Hagenah; Kemal Kabakci; Meike Kasten; Eberhard Schwinger; Jens Volkmann; Peter P. Pramstaller; Vladimir Kostic; Peter Vieregge; Christine Klein
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 95 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Mutations in LRRK2 (leucine‐rich repeat kinase 2) have been associated with autosomal dominant Parkinson's disease (PD) and cluster in several 3′ exons of the gene. The majority of mutations have been detected in late‐onset cases (age at onset >50 years). We screened 5 of the 51 exons of LRRK2 that previously have been reported to harbor mutations in 98 early‐onset and 42 late‐onset PD patients. We identified two mutations (c.4321C>T, c.6055G>A) in three early‐onset patients. Screening of an additional 220 early‐onset PD patients for these mutations revealed another mutation carrier. In conclusion, LRRK2 mutations need to be considered also in early‐onset PD. © 2006 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract Pathogenic __PINK1__ mutations have been described in PARK6‐linked Parkinson's disease (PD) patients of Asian origin. However, data on the frequency of __PINK1__ mutations in sporadic early‐onset Parkinson's disease (EOPD) Asian patients are lacking. The objectives of this study were to
## Abstract A multiethnic series of patients with early‐onset Parkinson's disease (EOP) was studied to assess the frequency and nature of __parkin__/PARK2 gene mutations and to investigate phenotype–genotype relationships. Forty‐six EOP probands with an onset age of <45 years, and 14 affected relat
## Abstract Mutations of __PLA2G6__ gene have been lately proposed to be the causative gene for PARK14 in patients with autosomal recessive young‐onset parkinsonism (YOPD). The role of __PLA2G6__ mutations as a risk factor for Parkinson's disease is not clear. To study the __PLA2G6__ mutations in P
## Abstract Parkinson's disease (PD) is characterized by progressive dopaminergic neuronal loss in the substantia nigra. The recent discovery of __leucine‐rich‐repeat kinase 2__ gene (__LRRK2__) mutations in PD is significant because these mutations are the most common cause of autosomal dominant P